Lilly Completes Acquisition of Loxo Oncology PR Newswire INDIANAPOLIS, Feb. 15, 2019 INDIANAPOLIS, Feb. 15, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today announced the successful...
By Kimberly Chin Eli Lilly and Co. (LLY) said it has slashed its earnings forecast to reflect the pending acquisition of Loxo Oncology Inc. (LOXO), as well as the costs of the ineffective clinical...
Lilly and Loxo Oncology Announce Expiration of HSR Act Waiting Period in Connection with Proposed Transaction PR Newswire INDIANAPOLIS and STAMFORD, Conn., Feb. 1, 2019 INDIANAPOLIS and STAMFORD...
Financialinsiders.com: 'Indexes Rise' Market News Recap Week Ending January 11th, 2019 Financialinsiders.com News Commentary PR Newswire NEW YORK, January 11, 2019 NEW YORK, January 11, 2019...
WEISSLAW LLP: Loxo Oncology, Inc. Acquisition May Not Be In The Best Interests of LOXO Shareholders PR Newswire NEW YORK, Jan. 8, 2019 NEW YORK, Jan. 8, 2019 /PRNewswire/ -- WeissLaw LLP is...
By Allison Prang and Peter Loftus This article is being republished as part of our daily reproduction of WSJ.com articles that also appeared in the U.S. print edition of The Wall Street Journal...
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Loxo Oncology, Inc. PR Newswire NEW YORK, Jan. 7, 2019 NEW YORK, Jan. 7, 2019 /PRNewswire/ -- Rowley Law PLLC is investigating...
By Will Horner and Akane Otani U.S. stocks rose Monday, boosted by rallying technology shares, as officials from Washington and Beijing kicked off their latest round of negotiations over trade...
By Allison Prang and Peter Loftus Eli Lilly & Co. said it is buying Loxo Oncology Inc. for $8 billion in cash, a deal that expands the biopharmaceutical company's oncology-treatment...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.